219 related articles for article (PubMed ID: 17379933)
1. Treating proteinuria in a diabetic patient despite hyperkalaemia due to hyporeninaemic hypoaldosteronism.
van Nieuwkoop C; Ijpelaar DH; Bolk JH
Neth J Med; 2007 Feb; 65(2):75-7. PubMed ID: 17379933
[TBL] [Abstract][Full Text] [Related]
2. [Risk for hyperkalemia during long-term treatment with angiotensin-converting enzyme inhibitors in insulin-dependent type 2 diabetics in relation to the glomerular filtration rate].
Raml A; Schmekal B; Grafinger P; Biesenbach G
Dtsch Med Wochenschr; 2001 Nov; 126(47):1327-30. PubMed ID: 11719857
[TBL] [Abstract][Full Text] [Related]
3. Persistent hyperkalaemia.
Xu B; Murray M
Aust Fam Physician; 2009 May; 38(5):307-9. PubMed ID: 19458800
[TBL] [Abstract][Full Text] [Related]
4. The antiproteinuric effect of antihypertensive agents in diabetic nephropathy.
Gansevoort RT; Apperloo AJ; Heeg JE; de Jong PE; de Zeeuw D
Arch Intern Med; 1992 Oct; 152(10):2137-9. PubMed ID: 1417388
[No Abstract] [Full Text] [Related]
5. Screening and treatment of diabetic renal disease.
Clement JD; Cottiero RA
Med Health R I; 1998 Nov; 81(11):348-9. PubMed ID: 15580788
[No Abstract] [Full Text] [Related]
6. Effects of different antihypertensive drugs on human diabetic proteinuria.
Weidmann P; Boehlen LM; de Courten M
Nephrol Dial Transplant; 1993; 8(7):582-4. PubMed ID: 8396739
[No Abstract] [Full Text] [Related]
7. [The treatment of diabetic nephropathy. The need for an early diagnosis].
Teruel Briones JL
Rev Clin Esp; 1999 Jan; 199(1):1-3. PubMed ID: 10089768
[No Abstract] [Full Text] [Related]
8. Reversible impairment of renal function associated with enalapril in a diabetic patient.
Albareda MM; Corcoy R
CMAJ; 1998 Nov; 159(10):1279-81. PubMed ID: 9861226
[TBL] [Abstract][Full Text] [Related]
9. Why patients with diabetes, hypertension and/or proteinuria are not on angiotensin converting enzyme inhibitors.
Gordian ME; Kelly J
Alaska Med; 1998; 40(3):51-4. PubMed ID: 9785612
[No Abstract] [Full Text] [Related]
10. Study of ACEI versus ARB in managing hypertensive overt diabetic nephropathy: long-term analysis.
Ozturk S; Sar F; Bengi-Bozkurt O; Kazancioglu R
Kidney Blood Press Res; 2009; 32(4):268-75. PubMed ID: 19776644
[TBL] [Abstract][Full Text] [Related]
11. [Kidney failure, proteinuria, and diabetic nephropathy].
Collart F
Rev Med Brux; 2003 Sep; 24(4):A257-62. PubMed ID: 14606290
[TBL] [Abstract][Full Text] [Related]
12. [Threatened diabetic nephropathy. Early administration of ACE inhibitors and AT1 blockers].
Einecke U
MMW Fortschr Med; 2002 Apr; 144(15):14. PubMed ID: 12004443
[No Abstract] [Full Text] [Related]
13. Severe hyperkalaemia due to mefenamic acid-induced hyporeninaemic hypoaldosteronism.
Chan JC; Chan TY; Ko TC; Chow CC; Critchley JA
Br J Clin Pract; 1995; 49(3):161-2. PubMed ID: 7779674
[TBL] [Abstract][Full Text] [Related]
14. Will the addition of pentoxifylline reduce proteinuria in patients with diabetic glomerulosclerosis refractory to maximal doses of both an angiotensin-converting enzyme inhibitor and an angiotensin receptor blocker?
Diskin CJ; Stokes TJ; Dansby LM; Radcliff L; Carter TB
J Nephrol; 2007; 20(4):410-6. PubMed ID: 17879206
[TBL] [Abstract][Full Text] [Related]
15. ACE inhibitors versus angiotensin receptor blockers in diabetic nephropathy: is there a winner?
Lewis EJ; Lewis JB
J Am Soc Nephrol; 2004 May; 15(5):1358-60. PubMed ID: 15100380
[No Abstract] [Full Text] [Related]
16. Hyperkalaemia in diabetes mellitus--potential hazards of coexisting hyporeninaemic hypoaldosteronism.
Large DM; Carr PH; Laing I; Davies M
Postgrad Med J; 1984 May; 60(703):370-3. PubMed ID: 6377287
[TBL] [Abstract][Full Text] [Related]
17. Treating diabetic nephropathy: unfinished success is not failure.
Lewis J
Clin J Am Soc Nephrol; 2007 May; 2(3):407-9. PubMed ID: 17699442
[No Abstract] [Full Text] [Related]
18. Effect of allopurinol in decreasing proteinuria in type 2 diabetic patients.
Momeni A; Shahidi S; Seirafian S; Taheri S; Kheiri S
Iran J Kidney Dis; 2010 Apr; 4(2):128-32. PubMed ID: 20404423
[TBL] [Abstract][Full Text] [Related]
19. [Angiotensin converting enzyme inhibitors in the treatment of diabetes].
Smahelová A
Vnitr Lek; 2003 Dec; 49(12):948-51. PubMed ID: 15040161
[No Abstract] [Full Text] [Related]
20. Transient hyperkalemia and hypoaldosteronism in a patient with acute glomerulonephritis.
Opastirakul S; Chartapisak W
J Med Assoc Thai; 2002 Apr; 85(4):509-13. PubMed ID: 12118500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
